Effects and safety of atrial natriuretic peptide administered to cirrhosis patients with ascites: a systematic review and meta-analysis - Forskning - Aarhus Universitet

Aarhus Universitets segl

Til studerende
Til ph.d.er
Til medarbejdere
Institutter og fakulteter
Bibliotek
Presse

Effects and safety of atrial natriuretic peptide administered to cirrhosis patients with ascites: a systematic review and meta-analysis

Publikation: Konferencebidrag › Poster › Forskning

Rasmus Hvidbjerg Birkbak Gantzel
Mikkel Breinholt Kjær
Peter Jepsen
Niels Kristian Aagaard
Hugh Robert Watson
Lise Lotte Gluud, Københavns Universitet
Henning Grønbæk

Institut for Klinisk Medicin - Lever-, Mave- og Tarmsygdomme

Originalsprog	Engelsk
Udgivelsesår	1 jul. 2021
Status	Udgivet - 1 jul. 2021
Begivenhed	ILC 2021 - The international liver congress (EASL): Beating liver disease together - Digital Varighed: 23 jun. 2021 → 26 jun. 2021 https://easl.eu/event/the-international-liver-congress-2021/

Konference

Konference	ILC 2021 - The international liver congress (EASL)
Lokation	Digital
Periode	23/06/2021 → 26/06/2021
Internetadresse	https://easl.eu/event/the-international-liver-congress-2021/

Se relationer på Aarhus Universitet Citationsformater

Projekter

Effects of urodilatin on natriuresis and diuresis in patients with liver cirrhosis and refractory ascites
Projekter: Projekt › Forskning

ID: 222334840